Behemoth Labz catalog trim

This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as November 2024. Sources for this entry are named inline below and numbered in full on the parent archive page.

Not a shutdown but a preemptive concession. As the December 2024 warning-letter wave was becoming clearly inevitable, Behemoth Labz removed injectables, peptides, and nootropics from its catalog. The business continued in a narrower form.

Why it still matters: the first visible case of a peer vendor voluntarily conceding regulatory ground. Set the template for the 2025-2026 pattern of pre-emptive catalog trimming.

← Back to the full Vendor Graveyard

Every verified shutdown, exit scam, and FDA action, 2018–2026, in one dated archive.